Why the study?
The necessity of bridging anticoagulation with low molecular weight heparin in atrial fibrillation patients interrupting warfarin for surgery or invasive procedures remains uncertain.
Key points are not available for this paper at this time.
Comparison
Bridging anticoagulation with LMWH vs no bridging
Design
Randomized, double-blind, placebo-controlled trial
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sang-Jin Han (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: